Real-world effectiveness of systemic anticancer therapy for advanced melanoma in the west of Scotland from 2010 to 2018-Reference-Cited by-同舟云学术

Real-world effectiveness of systemic anticancer therapy for advanced melanoma in the west of Scotland from 2010 to 2018

Published:2023-02 Issue:6 Volume:19 Page:451-461
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncol.

Author:

Clarke Julie¹²^ORCID,Bennie Marion²³^ORCID,Kurdi Amanj²⁴^ORCID,Pan Jiafeng⁵,Mueller Tanja²^ORCID,Crearie Christine¹,Baillie Kelly¹^ORCID,Laskey Jennifer¹,Waterston Ashita¹

Affiliation:

1. NHS Greater Glasgow & Clyde, Glasgow, G12 0XH, Scotland

2. Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, G4 0RE, Scotland

3. Public Health Scotland, Edinburgh, EH12 9EB, Scotland

4. Department of Pharmacology & Toxicology, College of Pharmacy, Hawler Medical University, Erbil, Iraq

5. Department of Mathematics & Statistics, University of Strathclyde, Glasgow, G1 1XH, Scotland

Funder

Scottish government

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/fon-2022-0959

Reference40 articles.

1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

3. Scottish Medicines Consortium . Ipilimumab (Yervoy) SMC Number (779/12) (2013). www.scottishmedicines.org.uk/medicines-advice/ipilimumab-yervoy-resubmission-77912/

4. Scottish Medicines Consortium . Ipilimumab (Yervoy) SMC Number (997/14) (2014). www.scottishmedicines.org.uk/medicines-advice/ipilimumab-yervoy-fullsubmission-99714/

5. CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma;Jedd D;J. Clin. Onc.,2021